About PDL BioPharma
PDL BioPharma is a company. It operates as a B2B, and B2C. PDL BioPharma has completed 3 acquisitions, including Eos Biotechnology, Noden Pharma DAC and TEKTURNA. PDL BioPharma offers products and services including Royalty Rights and Asset Liquidation Services.
- Stage Public
-
Sectors
HealthcareFinancial Services
-
Phone
*********
-
Website
*********
- Legal Name Pdl Biopharma, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$86.1 M (USD), Post-IPO
Sep 12, 2019
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Eos Biotechnology
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PDL BioPharma
PDL BioPharma offers a comprehensive portfolio of products and services, including Royalty Rights and Asset Liquidation Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Royalty rights from biopharmaceutical assets are managed and monetized as part of the dissolution process.
Assets are liquidated and claims are settled under the Plan of Dissolution to facilitate distributions.
Funding Insights of PDL BioPharma
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $86.1M
-
First Round
First Round
(18 Mar 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Post-IPO - PDL BioPharma | Valuation |
investors |
|
| Mar, 2009 | Amount | Grant - PDL BioPharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PDL BioPharma
PDL BioPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Research Council Canada. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Scientific and technological research is conducted for Canada's benefit.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PDL BioPharma
PDL BioPharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Eos Biotechnology, Noden Pharma DAC and TEKTURNA. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Producer of oil and clean-burning natural gas
|
2014 | ||||
|
Information on angiotensin is provided via a dedicated webpage.
|
2003 | ||||
|
Human antibody therapeutics are developed for cancer via genomics targets.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - PDL BioPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pdl Biopharma Comparisons
Competitors of PDL BioPharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PDL BioPharma
What does PDL BioPharma do?
PDL BioPharma is identified as a company that has undertaken dissolution proceedings, with the Plan of Dissolution approved by stockholders in August 2020 and the Certificate of Dissolution filed in January 2021. It is noted that the companys operations are wound down through the settlement of claims and distribution of assets under Delaware law, including the use of Safe Harbor Procedures to address liabilities. Assets such as royalty rights are monetized, and interim distributions have been made, with further actions overseen by the Delaware Court of Chancery to ensure proper handling of remaining funds and obligations.
What products or services does PDL BioPharma offer?
PDL BioPharma offers Royalty Rights and Asset Liquidation Services.
How many acquisitions has PDL BioPharma made?
PDL BioPharma has made 3 acquisitions, including Eos Biotechnology, Noden Pharma DAC, and TEKTURNA.
Who are PDL BioPharma's investors?
PDL BioPharma has 1 investor. Key investors include National Research Council Canada.